Want to join the conversation?
On July 17, a class action complaint was filed against $BDX, where the plaintiffs seek to represent a class of acute care purchasers of $BDX syringes and IV catheters. The complaint alleges that $BDX monopolized the markets for syringes and IV catheters through contracts, theft of technology, false ads acquisitions and other conduct.
What are your expectations from $COKE tomorrow?? Will the bear attack the beverage?
People seem to be cold about the $HAL earnings! Honestly, I expected more stock action by now.
$TSLA's Musk says Neuralink will take on AI prominence. Apparently, he wants to avoid a "Terminator" kind situation.
$JCP shares rebounded and now in green territory after saying it will hire 800 consultants as part of a beauty expansion that will include 70 new Sephora store-in-store locations.